Harris Erik
SEC insider (Form 3/4/5 filer). CIK 0001780113. EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc. (RARE) and 2 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Apr 16, 2026. Located in NOVATO, CA.
Companies Harris Erik has filed insider reports for
- Ultragenyx Pharmaceutical Inc. (RARE): Officer, EVP & Chief Commercial Officer
- Rezolute, Inc. (RZLT): Director
- Inozyme Pharma, Inc. (INZY): Director
Harris Erik
CIK: 0001780113
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Apr 16, 2026RARE
Ultragenyx Pharmaceutical Inc.
AwardDirect28.9K shares- - Mar 2, 2026RARE
Ultragenyx Pharmaceutical Inc.
SaleDirect10.5K shares at avg. $22.80$240K - Mar 1, 2026RARE
Ultragenyx Pharmaceutical Inc.
AwardDirect11.6K shares- - Nov 19, 2025RZLT
Rezolute, Inc.
AwardDirect21K shares- - Mar 25, 2025RZLT
Rezolute, Inc.
AwardDirectDirector Stock Option (Right to Buy)
60K shares- - Mar 3, 2025RARE
Ultragenyx Pharmaceutical Inc.
SaleDirect15.1K shares at avg. $42.10$636K - Mar 1, 2025RARE
Ultragenyx Pharmaceutical Inc.
AwardDirect16.8K shares- - Mar 1, 2025RARE
Ultragenyx Pharmaceutical Inc.
AwardDirect18.4K shares- - Oct 3, 2024INZY
Inozyme Pharma, Inc.
AwardDirectStock Option (right to buy)
56K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 16, 2026 |  RARE Ultragenyx Pharmaceutical Inc. | Award | 28,895 | - | $0 | Direct |
| Mar 2, 2026 | RARE Ultragenyx Pharmaceutical Inc. | Sale | 10,539 | $22.80 | $240,289 | Direct |
| Mar 1, 2026 | RARE Ultragenyx Pharmaceutical Inc. | Award | 11,643 | - | $0 | Direct |
| Nov 19, 2025 |  RZLT Rezolute, Inc. | Award | 21,000 | - | - | Direct |
| Mar 25, 2025 | RZLT Rezolute, Inc. | Award Director Stock Option (Right to Buy) | 60,000 | - | - | Direct |
| Mar 3, 2025 | RARE Ultragenyx Pharmaceutical Inc. | Sale | 15,103 | $42.10 | $635,836 | Direct |
| Mar 1, 2025 | RARE Ultragenyx Pharmaceutical Inc. | Award | 16,813 | - | - | Direct |
| Mar 1, 2025 | RARE Ultragenyx Pharmaceutical Inc. | Award | 18,443 | - | - | Direct |
| Oct 3, 2024 |  INZY Inozyme Pharma, Inc. | Award Stock Option (right to buy) | 56,000 | - | - | Direct |
1-9 of 9 transactions